These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 23718192)
1. Risperidone long-acting injection in Schizophrenia Spectrum Illnesses compared to first generation depot antipsychotics in an outpatient setting in Canada. Lammers L; Zehm B; Williams R BMC Psychiatry; 2013 May; 13():155. PubMed ID: 23718192 [TBL] [Abstract][Full Text] [Related]
2. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
3. Predictors for starting depot administration of risperidone in chronic users of antipsychotics. Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study. Barrio P; Batalla A; Castellví P; Hidalgo D; García M; Ortiz A; Grande I; Pons A; Parellada E Int Clin Psychopharmacol; 2013 Jul; 28(4):164-70. PubMed ID: 23587986 [TBL] [Abstract][Full Text] [Related]
5. Switching patients with stable schizophrenia or schizoaffective disorder from olanzapine to risperidone long-acting injectable. Rosa F; Schreiner A; Thomas P; Sherif T Clin Drug Investig; 2012 Apr; 32(4):267-79. PubMed ID: 22339430 [TBL] [Abstract][Full Text] [Related]
6. Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countries. Peuskens J; Olivares JM; Pecenak J; Tuma I; Bij de Weg H; Eriksson L; Resseler S; Akhras K; Jacobs A Curr Med Res Opin; 2010 Mar; 26(3):501-9. PubMed ID: 20014981 [TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome. Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343 [TBL] [Abstract][Full Text] [Related]
8. Diffusion of a new drug: a comparative analysis of adoption, treatment complexity, and persistence of risperidone long-acting injectable therapy in the Netherlands. Pechlivanoglou P; Vehof J; van Agthoven M; de Jong-van den Berg LT; Postma MJ Clin Ther; 2010 Jan; 32(1):108-18. PubMed ID: 20171417 [TBL] [Abstract][Full Text] [Related]
9. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I Encephale; 2005; 31(2):235-46. PubMed ID: 15959450 [TBL] [Abstract][Full Text] [Related]
14. Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patients. Taylor DM; Young CL; Mace S; Patel MX J Clin Psychiatry; 2004 Aug; 65(8):1076-83. PubMed ID: 15323592 [TBL] [Abstract][Full Text] [Related]
15. The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series. Se Hyun Kim ; Dong Chung Jung ; Yong Min Ahn ; Yong Sik Kim J Psychopharmacol; 2010 Jul; 24(7):981-6. PubMed ID: 19942641 [TBL] [Abstract][Full Text] [Related]
17. Prospective 6-month follow-up of patients prescribed risperidone long-acting injection: factors predicting favourable outcome. Taylor DM; Young C; Patel MX Int J Neuropsychopharmacol; 2006 Dec; 9(6):685-94. PubMed ID: 16939663 [TBL] [Abstract][Full Text] [Related]
18. Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review. Cañas F; Möller HJ Expert Opin Drug Saf; 2010 Sep; 9(5):683-97. PubMed ID: 20690885 [TBL] [Abstract][Full Text] [Related]
19. Paliperidone palmitate versus risperidone long-acting injection in markedly-to-severely ill schizophrenia subjects: onset of efficacy with recommended initiation regimens. Fu DJ; Bossie CA; Kern Sliwa J; Ma YW; Alphs L Clin Schizophr Relat Psychoses; 2014 Jul; 8(2):101-9, 109A. PubMed ID: 23446197 [TBL] [Abstract][Full Text] [Related]
20. Thirty-five months experience of risperidone long-acting injection in a UK psychiatric service including a mirror-image analysis of in-patient care. Niaz OS; Haddad PM Acta Psychiatr Scand; 2007 Jul; 116(1):36-46. PubMed ID: 17559599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]